Cheng, C.R., Yue, Q.X., Wu, Z.Y., Song, X.Y., Tao, S.J., Wu, X.H., Xu, P.P., Liu, X., Guan, S.H., Guo, D.A., 2010. Cytotoxic triterpenoids from Ganoderma lucidum. Phytochemistry. 71, 1579-85.
Chen, D.H., Shiou, W.Y., Wang, K.C., Huang, S.Y., Shie, Y.T., Tsai, C.M., Shie, J.F., Chen, K.D., 1999. Chemotaxonomy of triterpenoid
pattern of HPLC of Ganoderma lucidum and Ganoderma tsugae. J. Chin. Chem. Soc. 46, 47–51.
Chen, R.Y., YU, D.Q., 1990. Researche advances in triterpenoids from Ganoderma lucidum. Acta Pharmacceutica Sinica. 25, 940-953.
Gan, K.H., Fann, Y.F., Hsu, S.H., Kuo, K.W., Lin, C.N., 1998a.
Mediation of cytotoxicity of lanostanoids and steroids of Ganoderma
tsugae through apoptosis and cell cycle. J. Nat. Prod. 61, 485–487.
Grace, G.L., Fung, K.P., Tse, G.M., Leung, P.C., Lau, C.B., 2006. Comparative studies of various ganoderma species and their different parts with regard to their antitumor and immunomodulating activities in vitro. J Altern Complement Med. 12, 777-89.
Hsu, S,C., Ou, C.C., Chuang, T.C., Li, J.W., Lee, Y.J., Wang, V., Liu, J.Y., Chen, C.S., Lin, S.C., Kao, M.C., 2009. Ganoderma tsugae extract inhibits expression of epidermal growth factor receptor and angiogenesis in human epidermoid carcinoma cells: In vitro and in vivo. Cancer Lett. 281, 108-16.
Hsu, S.C., Ou, C.C., Li, J.W., Chuang, T.C., Kuo, H.P., Liu, J.Y., Chen, C.S., Lin, S.C., Su, C.H., Kao, M.C., 2008. Ganoderma tsugae extracts inhibit colorectal cancer cell growth via G(2)/M cell cycle arrest. J Ethnopharmacol. 120, 394-401.
Kikuchi, T., Kanomi (nee Matsuda), S., Kadota, S., Murai, Y., Tsubono, K. and Ogita, Z., 1986. Chem. Pharm. Bull. 34: 3695-3712.
Kikuchi, T., Matsuda, S., Kadota, S., Murai, Y and Ogita, Z., 1985. Chem. Pharm. Bull. 33, 2624.
Kikuchi, T., Matsuda, S., Kadota, S., Murai, Y and Ogita, Z. 1985., Chem. Pharm. Bull. 33, 2628.
Kimura, Y., Taniguchi, M., Baba, K., 2002. Antitumor and antimetastatic
effects on liver of triterpenoid fractions of Ganoderma lucidum:
mechanism of action and isolation of an active substance. Anticancer
Res. 22, 3309–3318.
Kubota, T., Y. Asaka, I. Miura and H. Mori., 1982. Structures of ganoderic acid A and B, two new lanostane type bitter triterpenes from Ganoderma lucidum (Fr.) Karst. Helv. Chim. Acta 65, 611–619.
Lin, Z.B., Zhang, H.N., 2004.Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms. Acta Pharmacol. Sin. 25, 1387–1395.
Liu, G.Q., Ding, C.Y., Wang, X.L., 2007. Mechanisms of anticancer action of triterpenoids from Ganoderma lucidum: A review of recent researches. Mycosystema 26, 470-476.
Liu, Y.W., Gao,J.L., Guan, J., Qian,Z.M., Feng. K., Li, S.P., 2009. Evaluation of Antiproliferative Activities and Action Mechanisms of Extracts from Two Species of Ganoderma on Tumor Cell Lines. J. Agric. Food Chem. 57, 3087–3093.
Luo, J. and Lin, Z.B., 2002. Advances of pharmacological effects of triterpenes from Ganoderma lucidum. Acta Pharm. Sin. 37, 574–578.
Mizuno, T., Wang, G., Zhang, J., Kawagishi, H., Nishitoba, T., Li, J., 1995. Ganoderma lucidum and Ganoderma tsugae: Bioactive substances and medicinal effects. Food Rev. Intern. 11, 151-166.
Nishitoba, T., Sato, H., Sakamura, S., 1987. Triterpenoids from the fungus Ganoderma lucidum. Phytochemistry 26, 1777-1784.
Paterson, R.R., 2006. Ganoderma-a therapeutic fungal biofactory. Phytochemistry 67, 1985–2001.
Shiao, M.-S., Lin, L.-J., Yeh, S.-F., 1988. Triterpenes in Ganoderma
lucidum. Phytochemistry 27, 873–875.
Wu, T.S., Shi, L.S.,Kuo, S.C., 2001. Cytotoxicity of Ganoderma lucidum triterpenes. J. Nat. Prod. 64, 1121-1122.
Xing, Z., Yu, Q., Zhang, J., Pan Y., 2004. Zhong Yao Cai. 27, 575-6.
Yu, Y.H., Kuo, H.P., Hsieh, H.H., Li, J.W., Hsu, W.H., Chen, S.J., Su, M.H., Liu, S.H., Cheng, Y.C., Chen*, C.Y., Kao*, M.C., 2012. Ganoderma tsugae Induces S Phase Arrest and Apoptosis in Doxorubicin-Resistant Lung Adenocarcinoma H23/0.3 Cells via Modulation of the PI3K/Akt Signaling Pathway. Evid Based Complement Alternat Med. 2012: 371286.
Zhou X., Lin J., Yin Y., Zhao J., Sun X., Tang K., 2007. Ganodermataceae: natural products and their related pharmacological functions. Am J Chin Med. 35, 559-74.
王以均. 2007. 應用蛋白質體學技術探討松杉靈萃取物抑制人類卵巢癌細胞株SKOV-3生長之分子機轉. 中國醫藥大學基礎醫學研究所,碩士論文.李佩怡. 2009. 應用蛋白質體學方法探討松杉靈萃取物抑制口腔癌細
胞的生長. 中國醫藥大學基礎醫學研究所,碩士論文.